CRWV insider sale notice: 250K founder shares, August 2025 10b5-1 sales disclosed

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) Form 144 notice shows a proposed sale of 250,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $23,095,000 and approximately 370,470,348 shares outstanding. The sale is described as approximately occurring on 08/26/2025.

The filer reports these 250,000 shares were acquired as Founders Shares on 11/13/2017 from the issuer. The filing also lists recent related sales during the past three months: 250,000 shares sold on 08/19/2025 for $22,926,475 and 375,000 shares sold on 08/19/2025 for $34,389,712.50, noted as 10b5-1 sales for related parties. The notice includes the standard representation that the seller does not possess undisclosed material adverse information.

Positive

• Disclosure compliance: The filer provides required Rule 144 and 10b5-1 sale details, including broker, acquisition date, and market values
• Transparency on acquisition: Shares identified as founders shares with original acquisition date (11/13/2017), clarifying holding history

Negative

• Insider selling: Proposed sale of 250,000 shares and recent 10b5-1 sales totaling 625,000 shares could be viewed negatively by some investors
• Concentration of proceeds: Recent gross proceeds reported ($57,316,187.50 combined) indicate meaningful insider liquidity in August 2025

Insights

Securities Analyst

TL;DR Insider-related sale notice for 250,000 founder shares and recent 10b5-1 sales totaling 625,000 shares in August 2025.

The filing documents a proposed sale of 250,000 common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $23.095 million against roughly 370.47 million shares outstanding, indicating a small single-transaction dilution relative to total float. The shares were acquired as founders shares on 11/13/2017. The filing also discloses two 10b5-1 program sales on 08/19/2025 totaling 625,000 shares with combined gross proceeds of $57,316,187.50. All information is procedural and compliant with Rule 144 and 10b5-1 disclosure requirements.

Corporate Governance Expert

TL;DR Routine Form 144 disclosure of founder share sale and prior 10b5-1 sales; contains the seller's attestation about material nonpublic information.

The notice includes the seller's representation that they are not aware of undisclosed material adverse information and cites the plan adoption/instruction context for 10b5-1 sales. The filing lists acquisition details (founders shares, 11/13/2017) and transaction counterpart (Morgan Stanley Smith Barney LLC). No additional governance events or departures are disclosed in this document.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	250000	23095000.00	370470348	08/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			250000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Livingston NJ 07039	Common	08/19/2025	250000	22926475.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Livingston NJ 07039	Common	08/19/2025	375000	34389712.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for CRWV disclose?

The filing discloses a proposed sale of 250,000 common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $23,095,000 and ~370,470,348 shares outstanding.

When were the shares to be sold originally acquired?

The 250,000 shares were acquired as Founders Shares on 11/13/2017 from the issuer.

Were there recent related sales reported in the filing?

Yes. The filing lists 10b5-1 sales on 08/19/2025: 250,000 shares for $22,926,475 and 375,000 shares for $34,389,712.50.

Which broker is handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY.

Does the filer attest to any undisclosed material information?

The filer signs a representation that they do not know any material adverse information about the issuer that has not been publicly disclosed.